734
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

Chiral resolution, determination of absolute configuration, and biological evaluation of (1,2-benzothiazin-4-yl)acetic acid enantiomers as aldose reductase inhibitors

, , , , , , & show all
Pages 846-851 | Received 03 Aug 2014, Accepted 31 Aug 2014, Published online: 27 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xin Hao, Gang Qi, Hongxing Ma, Changjin Zhu & Zhongfei Han. (2019) Novel 2-phenoxypyrido[3,2-b]pyrazin-3(4H)-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 1368-1372.
Read now

Articles from other publishers (4)

Xiaonan Zhang, Huan Chen, Xin Zhang, Long Xu, Yanqi Lei, Wenchao Liu, Lingyun Li, Hulin Xu, Changjin Zhu & Bing Ma. (2022) β-Aldehyde ketones as dual inhibitors of aldose reductase and α-glucosidase with antioxidant properties. New Journal of Chemistry 46:13, pages 6165-6173.
Crossref
Xin Hao, Xiangyu Qin, Xin Zhang, Bing Ma, Gang Qi, Taiming Yu, Zhongfei Han & Changjin Zhu. (2019) Identification of quinoxalin-2(1 H )-one derivatives as a novel class of multifunctional aldose reductase inhibitors . Future Medicinal Chemistry 11:23, pages 2989-3004.
Crossref
Koffi Sénam Etsè, Benjamin Dassonneville, Guillermo Zaragoza & Albert Demonceau. (2017) One-pot, Pd/Cu-catalysed synthesis of alkynyl-substituted 3-ylidene-dihydrobenzo[d]isothiazole 1,1-dioxides. Tetrahedron Letters 58:8, pages 789-793.
Crossref
Zhongfei Han, Xin Hao, Bing Ma & Changjin Zhu. (2016) A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity. European Journal of Medicinal Chemistry 121, pages 308-317.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.